FI841369A - Ph-oberoende, kontrollerat frigoerande tablett. - Google Patents

Ph-oberoende, kontrollerat frigoerande tablett. Download PDF

Info

Publication number
FI841369A
FI841369A FI841369A FI841369A FI841369A FI 841369 A FI841369 A FI 841369A FI 841369 A FI841369 A FI 841369A FI 841369 A FI841369 A FI 841369A FI 841369 A FI841369 A FI 841369A
Authority
FI
Finland
Prior art keywords
dipyridamole
acid
kontrollerat
frigoerande
oberoende
Prior art date
Application number
FI841369A
Other languages
English (en)
Other versions
FI82604B (fi
FI82604C (fi
FI841369A0 (fi
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of FI841369A0 publication Critical patent/FI841369A0/fi
Publication of FI841369A publication Critical patent/FI841369A/fi
Publication of FI82604B publication Critical patent/FI82604B/fi
Application granted granted Critical
Publication of FI82604C publication Critical patent/FI82604C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI841369A 1983-04-08 1984-04-06 Foerfarande foer framstaellning av oral reglertablett. FI82604C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08
US48328583 1983-04-08

Publications (4)

Publication Number Publication Date
FI841369A0 FI841369A0 (fi) 1984-04-06
FI841369A true FI841369A (fi) 1984-10-09
FI82604B FI82604B (fi) 1990-12-31
FI82604C FI82604C (fi) 1991-04-10

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841369A FI82604C (fi) 1983-04-08 1984-04-06 Foerfarande foer framstaellning av oral reglertablett.

Country Status (20)

Country Link
EP (1) EP0121901B1 (fi)
JP (1) JPS6034906A (fi)
KR (1) KR880002139B1 (fi)
AT (1) ATE32980T1 (fi)
AU (1) AU570446B2 (fi)
CA (1) CA1219216A (fi)
DD (1) DD222496A5 (fi)
DE (1) DE3469848D1 (fi)
DK (1) DK166259C (fi)
ES (1) ES531346A0 (fi)
FI (1) FI82604C (fi)
GR (1) GR81907B (fi)
HU (1) HU191542B (fi)
IE (1) IE57220B1 (fi)
IL (1) IL71458A (fi)
NO (1) NO164958C (fi)
NZ (1) NZ207768A (fi)
PH (1) PH21585A (fi)
PT (1) PT78380B (fi)
ZA (1) ZA842562B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
KR20080037732A (ko) * 2005-08-22 2008-04-30 노파르티스 아게 ｐＨ-의존성 약물, ｐＨ 개질제 및 지연제를 포함하는제약학적 조성물
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
NO164958B (no) 1990-08-27
KR880002139B1 (ko) 1988-10-17
FI82604B (fi) 1990-12-31
JPH0521892B2 (fi) 1993-03-25
AU570446B2 (en) 1988-03-17
IL71458A (en) 1987-09-16
ES8601687A1 (es) 1985-11-01
HU191542B (en) 1987-03-30
FI82604C (fi) 1991-04-10
NO841372L (no) 1984-10-09
NZ207768A (en) 1987-02-20
IE57220B1 (en) 1992-06-03
EP0121901A1 (en) 1984-10-17
DK166259C (da) 1993-08-23
DK181084D0 (da) 1984-04-06
DK181084A (da) 1984-10-09
DD222496A5 (de) 1985-05-22
JPS6034906A (ja) 1985-02-22
DE3469848D1 (en) 1988-04-21
ATE32980T1 (de) 1988-04-15
KR840008588A (ko) 1984-12-17
FI841369A0 (fi) 1984-04-06
GR81907B (fi) 1984-12-12
IE840856L (en) 1984-10-08
PT78380B (en) 1986-08-14
ZA842562B (en) 1985-12-24
ES531346A0 (es) 1985-11-01
IL71458A0 (en) 1984-07-31
EP0121901B1 (en) 1988-03-16
CA1219216A (en) 1987-03-17
DK166259B (da) 1993-03-29
HUT34345A (en) 1985-03-28
AU2660984A (en) 1984-10-11
PH21585A (en) 1987-12-11
PT78380A (en) 1984-05-01
NO164958C (no) 1990-12-05

Similar Documents

Publication Publication Date Title
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69212882D1 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
FI895342A0 (fi) Ibuprofen-brusprodukter.
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
IL83032A0 (en) Pharmaceutical compositions containing calcium salts and their preparation
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
FI841369A (fi) Ph-oberoende, kontrollerat frigoerande tablett.
DE3873167T2 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
ATE84220T1 (de) Injektionszusammensetzung, die modifiziertes tpa enthaelt.
JPS562977A (en) *33alkylaminoo22hydroxypropoxy**furann22 carboxylic acid anilide and its addition salt* its manufacture and medicinal composition containing it
DK160388A (da) Tert-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 og syreadditionssalte deraf til anvendelse som terapeutisk aktivt stof
BE862305A (fr) 2-bromo-3-chloro-n-2-imidazolidinylidene-benzamine, ses sels d'addition avec des acides, medicaments la renfermant et procedes pour sa preparation

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM LTD.